These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 15651986

  • 1. Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis.
    Marini P, Schmid A, Jendrossek V, Faltin H, Daniel PT, Budach W, Belka C.
    BMC Cancer; 2005 Jan 14; 5():5. PubMed ID: 15651986
    [Abstract] [Full Text] [Related]

  • 2. The sequential treatment with ionizing radiation followed by TRAIL/Apo-2L reduces tumor growth and induces apoptosis of breast tumor xenografts in nude mice.
    Shankar S, Singh TR, Chen X, Thakkar H, Firnin J, Srivastava RK.
    Int J Oncol; 2004 May 14; 24(5):1133-40. PubMed ID: 15067334
    [Abstract] [Full Text] [Related]

  • 3. Combined treatment of colorectal tumours with agonistic TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: enhanced effects in vitro and dose-dependent growth delay in vivo.
    Marini P, Denzinger S, Schiller D, Kauder S, Welz S, Humphreys R, Daniel PT, Jendrossek V, Budach W, Belka C.
    Oncogene; 2006 Aug 24; 25(37):5145-54. PubMed ID: 16636678
    [Abstract] [Full Text] [Related]

  • 4. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms.
    Shankar S, Singh TR, Srivastava RK.
    Prostate; 2004 Sep 15; 61(1):35-49. PubMed ID: 15287092
    [Abstract] [Full Text] [Related]

  • 5. Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.
    Johnsen JI, Pettersen I, Ponthan F, Sveinbjørnsson B, Flaegstad T, Kogner P.
    Int J Oncol; 2004 Dec 15; 25(6):1849-57. PubMed ID: 15547726
    [Abstract] [Full Text] [Related]

  • 6. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.
    Keane MM, Ettenberg SA, Nau MM, Russell EK, Lipkowitz S.
    Cancer Res; 1999 Feb 01; 59(3):734-41. PubMed ID: 9973225
    [Abstract] [Full Text] [Related]

  • 7. [Death inducing ligands in combination with ionizing radiation: objective and current knowledge].
    Belka C, Betsch A, Marini P, Jendrossek V, Bamberg M, Budach W.
    Strahlenther Onkol; 2003 Mar 01; 179(3):141-51. PubMed ID: 12627256
    [Abstract] [Full Text] [Related]

  • 8. Caspase 8-dependent sensitization of cancer cells to TRAIL-induced apoptosis following reovirus-infection.
    Clarke P, Meintzer SM, Spalding AC, Johnson GL, Tyler KL.
    Oncogene; 2001 Oct 18; 20(47):6910-9. PubMed ID: 11687970
    [Abstract] [Full Text] [Related]

  • 9. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
    Hesry V, Piquet-Pellorce C, Travert M, Donaghy L, Jégou B, Patard JJ, Guillaudeux T.
    Prostate; 2006 Jun 15; 66(9):987-95. PubMed ID: 16541419
    [Abstract] [Full Text] [Related]

  • 10. TRAIL and chemotherapeutic drugs in cancer therapy.
    Wu XX, Ogawa O, Kakehi Y.
    Vitam Horm; 2004 Jun 15; 67():365-83. PubMed ID: 15110186
    [Abstract] [Full Text] [Related]

  • 11. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells.
    Hyer ML, Croxton R, Krajewska M, Krajewski S, Kress CL, Lu M, Suh N, Sporn MB, Cryns VL, Zapata JM, Reed JC.
    Cancer Res; 2005 Jun 01; 65(11):4799-808. PubMed ID: 15930300
    [Abstract] [Full Text] [Related]

  • 12. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells.
    Shiraishi T, Yoshida T, Nakata S, Horinaka M, Wakada M, Mizutani Y, Miki T, Sakai T.
    Cancer Res; 2005 Jul 15; 65(14):6364-70. PubMed ID: 16024639
    [Abstract] [Full Text] [Related]

  • 13. The topoisomerase I inhibitor topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced apoptosis.
    Griffith TS, Kemp TJ.
    Cancer Chemother Pharmacol; 2003 Sep 15; 52(3):175-84. PubMed ID: 12811515
    [Abstract] [Full Text] [Related]

  • 14. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD, Wu JJ, Gillespie S, Borrow J, Hersey P.
    Clin Cancer Res; 2006 Feb 15; 12(4):1355-64. PubMed ID: 16489094
    [Abstract] [Full Text] [Related]

  • 15. Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells.
    Lashinger LM, Zhu K, Williams SA, Shrader M, Dinney CP, McConkey DJ.
    Cancer Res; 2005 Jun 01; 65(11):4902-8. PubMed ID: 15930312
    [Abstract] [Full Text] [Related]

  • 16. Time sequence of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and cisplatin treatment is responsible for a complex pattern of synergistic cytotoxicity.
    Kim YH, Lee YJ.
    J Cell Biochem; 2006 Aug 01; 98(5):1284-95. PubMed ID: 16514644
    [Abstract] [Full Text] [Related]

  • 17. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
    Rubinchik S, Yu H, Woraratanadharm J, Voelkel-Johnson C, Norris JS, Dong JY.
    Cancer Gene Ther; 2003 Nov 01; 10(11):814-22. PubMed ID: 14605667
    [Abstract] [Full Text] [Related]

  • 18. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
    Park SJ, Wu CH, Choi MR, Najafi F, Emami A, Safa AR.
    Biochem Pharmacol; 2006 Jul 28; 72(3):293-307. PubMed ID: 16753135
    [Abstract] [Full Text] [Related]

  • 19. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines.
    Kim DM, Koo SY, Jeon K, Kim MH, Lee J, Hong CY, Jeong S.
    Cancer Res; 2003 Feb 01; 63(3):621-6. PubMed ID: 12566305
    [Abstract] [Full Text] [Related]

  • 20. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.
    Frese S, Frese-Schaper M, Andres AC, Miescher D, Zumkehr B, Schmid RA.
    Cancer Res; 2006 Jun 01; 66(11):5867-74. PubMed ID: 16740726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.